Executive Summary

Aier Eye Hospital Group and MedImaging Integrated Solutions (MiiS) developed a deep-learning solution to improve screening for diabetic retinopathy and age-related macular degeneration. But the team wasn’t satisfied with the performance or cost profile it was seeing from its original architecture. MiiS worked with Intel to explore whether Intel® architecture could deliver better performance for practical clinical workflows. The speedups were so impressive that MiiS and Aier are moving forward with an Intel® Xeon® Scalable processor-based appliance for clinical inferencing in community clinics and small hospitals.